Aminologics Co.,Ltd. (KOSDAQ:074430)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,179.00
-1.00 (-0.08%)
At close: Sep 3, 2026

Aminologics Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
26,15822,02016,79020,88727,33722,849
Revenue Growth
64.47%31.15%-19.61%-23.60%19.64%29.45%
Gross Profit
12,3699,8323,3847,73412,7909,128
Operating Income
5,4793,594-2,1531,4626,9083,953
Net Income
3,1593,522-1,6202,436-7,2825,360
Earnings Per Share
35.9740.10-18.0027.74-82.9161.03
EPS Growth
-----150.46%

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
53,23963,03235,38228,49929,23825,663
Total Debt
16,84516,2142,0181,8191,9891,654
Net Cash (Debt)
36,39546,81733,36426,68027,24924,010
Net Cash Growth
21.34%40.32%25.05%-2.09%13.49%1.29%
Net Cash Per Share
414.39533.07370.70303.78310.26273.38

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,7642,5417,466-218.155,226935.52
Capital Expenditures
-75.7-45.7-511.5-155.8-490.2-515.71
Free Cash Flow
1,6882,4956,955-373.954,736419.81
Free Cash Flow Growth
-73.83%-64.13%--1028.11%-71.24%

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
47.29%44.65%20.16%37.03%46.79%39.95%
Operating Margin
20.95%16.32%-12.82%7.00%25.27%17.30%
Pretax Margin
17.90%15.96%-6.58%10.97%-22.98%16.21%
Profit Margin
12.08%15.99%-9.65%11.66%-26.64%23.46%
FCF Margin
6.45%11.33%41.42%-1.79%17.32%1.84%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
31.2829.78-48.45-35.97
P/FCF Ratio
58.7442.0311.34-33.94459.21
PS Ratio
3.794.764.705.655.888.44